Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects ∼40% of type 1 and type 2 diabetic patients. It increases the risk of death, mainly from cardiovascular causes, and is defined by increased urinary albumin excretion (UAE) in the absence of other renal diseases.

As almost a third of people (globally) with diabetes develop diabetic nephropathy, it is critical to address the associated risk factors and assess, analyze and communicate the risks. People with diabetes also are more likely to have other kidney-related problems, such as bladder infections and nerve damage to the bladder. So, it is imperative to assess the risks and create the appropriate next steps towards screening, diagnosis, continuous monitoring as part of prognosis and deliver digital health interventions.

In India, as per Senior Nephrologists, 65% of the diabetes people are turning up in dialysis. Given that more than 34 million dialysis patients exist, it is clear that this a top issue to address and curb, delay the onset of CKD to stop or reduce the raise in dialysis cases.

Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes. High blood sugar (glucose) can injure nerves throughout your body. Diabetic neuropathy most often damages nerves in your legs and feet. For example, in the US, more than 200,000 cases per year are reported. The final stage of nephropathy is called kidney failure, end-stage renal disease, or ESRD.